Scipher Medicine Reports Positive Results for Prism, a Drug Response Test That Can Save the Health Insurance Industry $20 Billion by Avoiding Paying for Ineffective Therapies The blood test ensures patients with autoimmune diseases are prescribed the most effective...
WALTHAM, Mass., Sept. 6, 2018 /PRNewswire/ — Scipher Medicine, developer of a molecular technology platform that can predict if a patient will actually respond to a particular drug therapy announced today that it has completed its Series A round led by...
